Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6132.5000 32.00 (0.52%)
NSE Aug 14, 2025 15:31 PM
Volume: 407.1K
 

6132.50
0.52%
ICICI Securities Limited
More than strong half-yearly performance (the management stresses that in a business like this can be lumpy) important narrative for Divi's is unprecedented capex to further augment capacities besides preparing for growing opportunities arising due to China plus one factor. It has earmarked an aggressive capex of ~| 3700 crore [| 1800 (existing plans) + | 400 (custom synthesis blocks) + | 1500 (greenfield Kakinada plant) crore], over and above ~| 2000 crore spent in last five years. Divi's remains a quintessential play on the Indian API/CRAMs segment with its product...
Divi's Laboratories Ltd. is trading below its 30 day SMA of 6554.6
More from Divi's Laboratories Ltd.
Recommended